Peer Review History

Original SubmissionJune 26, 2025
Decision Letter - Ajit Prakash, Editor

Dear Dr. Hardy,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 29 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Ajit Prakash, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that this submission includes NMR spectroscopy data. We would recommend that you include the following information in your methods section or as Supporting Information files:

1) The make/source of the NMR instrument used in your study, as well as the magnetic field strength. For each individual experiment, please also list: the nucleus being measured; the sample concentration; the solvent in which the sample is dissolved and if solvent signal suppression was used; the reference standard and the temperature.

2) A list of the chemical shifts for all compounds characterised by NMR spectroscopy, specifying, where relevant: the chemical shift (δ), the multiplicity and the coupling constants (in Hz), for the appropriate nuclei used for assignment.

3)The full integrated NMR spectrum, clearly labelled with the compound name and chemical structure.

We also strongly encourage authors to provide primary NMR data files, in particular for new compounds which have not been characterised in the existing literature. Authors should provide the acquisition data, FID files and processing parameters for each experiment, clearly labelled with the compound name and identifier, as well as a structure file for each provided dataset. See our list of recommended repositories here: https://journals.plos.org/plosone/s/recommended-repositories .

3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.  

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Summary:

This manuscript describes the successful optimization of an NMR sample preparation protocol for Caspase-6, a self-degrading protease that has been historically difficult to study using solution NMR. The authors systematically test different growth, purification, and buffer exchange conditions to obtain stable, concentrated, isotopically labeled samples. Their optimized protocol improves yield and spectral quality by eliminating steps that cause protein loss, such as anion exchange and spin filtration. The study also evaluates multiple constructs and conditions to find one that is NMR-compatible. This work offers practical guidance for other researchers working on similarly unstable or low-yield proteins.

Strengths:

1. The study addresses a longstanding technical challenge in the preparation of an NMR-compatible form of Caspase-6, a self-cleaving and aggregation-prone protease.

2. The experimental design is thorough and data-driven leading to a final protocol that is simple, reproducible, and avoids problematic steps like anion exchange and centrifugal concentration.

3. The authors choose an appropriate construct (D179CT) and NMR approach (Ileδ1 13CH3 methyl HMQC) for a first step in structural work.

4. The manuscript is well organized, and the conclusions are well supported by experimental outcomes.

5. The work is broadly applicable to researchers preparing dynamic or unstable proteins for biophysical characterization.

Major Comments:

1. The manuscript states that Ni-affinity purification alone provided sufficient purity and improved yield. However, this claim would be stronger if the authors included direct comparisons of yield, concentration, and purity between samples that did and did not undergo anion exchange. An SDS-PAGE image or protein quantification comparing the two workflows would be useful.

2. The authors should clarify in the Introduction or early Results that spin filters caused significant sample loss and were avoided throughout the workflow. Including specific protein recovery data comparing desalting columns to centrifugal filters will support this decision and strengthen the general takeaway.

3. The various optimizations are scattered throughout the text. A summary comparing the initial and final workflows with numerical data for yield (mg/L), concentration (µM), recovery %, and NMR suitability would help readers quickly understand the benefits of each change.

4. The authors should report how many Ileδ1 methyl peaks were observed in the HMQC spectrum relative to the expected number based on sequence. This will help assess how well-folded and NMR-ready the sample is.

5. The authors should comment on signal-to-noise ratio, chemical shift dispersion, and linewidth in the methyl HMQC spectrum. Even if qualitative, this information will support claims of spectral quality and sample integrity.

6. The authors should assess how stable the Caspase-6 samples are over a 24- to 48- hour period at room temperature or 25°C. Overlays of spectra at different time points or a description of peak loss or aggregation would help others plan experiments using this protocol.

7. If the authors have successfully expressed and collected a 1H-15N HSQC spectrum for the full-length C163S variant, it would be valuable to include this data, even if unassigned. This will strengthen the claim that the optimized protocol supports analysis of other constructs.

8. The manuscript states that these findings may apply to other proteases. The authors should be more specific about which steps, such as choice of Tris pH 8.5, inclusion of DTT, use of glycerol, or buffer exchange strategy, are likely to benefit other unstable or aggregation-prone proteins.

Minor Comments:

1. Standardize the use of “Caspase-6” or “Casp-6” throughout the manuscript for consistency.

2. Ensure that all figures (particularly Fig 2A, 2C, 3B, 4B, 6A-D) include properly labeled axes, units, and legends. Clarify what the error bars represent (SD or SEM), and indicate the number of replicates (n).

3. In the Methods section, clarify whether IPTG concentration, growth temperature, and induction timing were fixed based on prior studies or tested as part of this optimization.

4. All supplemental materials (S1 Protocol, S1 Fig, S2 Table) should be cited at appropriate points in the main text where their content is relevant. Avoid listing them only in the Supporting Information section.

5. In the abstract, revise the sentence “it remained impossible to analyze caspase-6 by NMR” to something more direct, such as “Prior attempts to analyze Caspase-6 by NMR failed due to challenges in sample preparation.”

Reviewer #2: The section is scientifically sound and well-documented, but it would benefit from:

Condensing repeated explanations,

Providing brief quantitative context when referencing figures,

Structuring into smaller paragraphs for readability,

Emphasizing the key conclusion more prominently.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  DR SAI KUMAR BADAM

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: An NMR Sample Preparation Case Study.pdf
Revision 1

We thank the reviewers for their attention and time in providing a very comprehensive review. We have provided a thorough and point-by-point response in the "Response to Reviewers" document.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Ajit Prakash, Editor

An NMR Sample Preparation Case Study: Considerations for the Self-Destructive Protease Caspase-6

PONE-D-25-34737R1

Dear Dr. Hardy,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ajit Prakash, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  Dr. SAI KUMAR BADAM

**********

Formally Accepted
Acceptance Letter - Ajit Prakash, Editor

PONE-D-25-34737R1

PLOS ONE

Dear Dr. Hardy,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ajit Prakash

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .